A new study recently released has shown that some men do not benefit from early prostate screening. The study has shown that men, ages 55 to 74 who show low amount of prostate specific antigen, or PSA, stand to gain no benefit from early screening.
While the rate of prostate cancer in the western world is one of the highest among all types of cancer, the risk of death from the condition is relatively low. Only around 2.8 percent of men who develop prostate cancer will actually die from the condition.
It’s been long questioned whether routine PSA testing stands any benefit for men. According to the study, continued screening for these men will not only have little to no effect on the rate of mortality for these patients, should they develop the condition, but also has a negative effect on their quality of life.
The study used data from a large study that was conducted in Europe between 1993 and 1999, and found that the men for this age group, who showed low amounts of PSA did not stand to benefit from screening. In total, over 42,000 men comprised the group that was evaluated.
While the study may encourage some to stop screening, all involved strongly recommend that a physician be consulted before that decision is made.